Land: Nederland
Taal: Nederlands
Bron: CBG-MEB (College ter Beoordeling van Geneesmiddelen)
DESOGESTREL 150 µg/stuk ; ETHINYLESTRADIOL 30 µg/stuk
Teva Nederland B.V. Swensweg 5 2031 GA HAARLEM
G03AA09
DESOGESTREL 150 µg/stuk ; ETHINYLESTRADIOL 30 µg/stuk
Tablet
AARDAPPELZETMEEL ; LACTOSE 0-WATER ; POVIDON K 30 (E 1201) ; SILICIUMDIOXIDE (E 551) ; STEARINEZUUR (E 570) ; TOCOFEROL, DL-ALFA (E 307),
Oraal gebruik
Desogestrel And Ethinylestradiol
Hulpstoffen: AARDAPPELZETMEEL; LACTOSE 0-WATER; POVIDON K 30 (E 1201); SILICIUMDIOXIDE (E 551); STEARINEZUUR (E 570); TOCOFEROL, DL-ALFA (E 307);
2013-06-06
Desogestrel/Ethinylestradiol, NL/H/2673/002, 03.04.2023 rvg 112201 EU PIL II/025 met NL info-clean BIJSLUITER: INFORMATIE VOOR DE GEBRUIKER Ethinylestradiol/Desogestrel 0,03 mg/0,15 mg Teva, tabletten desogestrel/ethinylestradiol IMPORTANT THINGS TO KNOW ABOUT COMBINED HORMONAL CONTRACEPTIVES (CHCS): • They are one of the most reliable reversible methods of contraception if used correctly • They slightly increase the risk of having a blood clot in the veins and arteries, especially in the first year or when restarting a combined hormonal contraceptive following a break of 4 or more weeks • Please be alert and see your doctor if you think you may have symptoms of a blood clot (see section 2 “Blood clots”) READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. _•_ Keep this leaflet. You may need to read it again. • If you have any further questions, ask your doctor or pharmacist. • This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. • If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4. WHAT IS IN THIS LEAFLET 1. What __ is and what it is used for 2. What you need to know before you take _ Lees het volledige document_ 3. How to take _ _ 4. Possible side effects 5. How to store _ _ 6. Contents of the pack and other information 1. WHAT _ _ IS AND WHAT IT IS USED FOR COMPOSITION AND TYPE OF PILL _ _ tablet is a combined oral contraceptive pill, also called the combined pill. Each tablet contains a small amount of two types of female hormones, namely, a progestogen, desogestrel and an oestrogen, ethinylestradiol. Because of the small amount of hormones, _ _ is considered a low-dose contraceptive. Because both hormones are combined in the same quantity in all tablets in the strip, it
Desogestrel/Ethinylestradiol, tablets, NL/H/2673/002, 03.04.2023 rvg 112201 EU SPC II-025 met NL info-clean SUMMARY OF PRODUCTS CHARACTERISTICS 1. NAAM VAN HET GENEESMIDDEL Ethinylestradiol/Desogestrel 0,03 mg/0,15 mg Teva, tabletten _ _ 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each tablet contains 150 micrograms desogestrel and 30 micrograms ethinylestradiol. Excipients with known effect: Each tablet contains 58 mg lactose. For the full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Tablet Each tablet is round, white to off-white, 5.00 mm, uncoated, biconvex, debossed with ‘142’ on one side and other side plain. 4. CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Oral contraception The decision to prescribeshould take into consideration the individual woman’s current risk factors, particularly those for venous thromboembolism (VTE), and how the risk of VTE with Lees het volledige documentcompares with other CHCs (see sections 4.3 and 4.4). 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Posology HOW TO TAKE The tablets must be taken every day at about the same time, if necessary with a little liquid, in the order shown on the blister pack. One tablet is to be taken daily for 21 consecutive days. Each subsequent pack is started after a 7-day tablet-free interval; during which time a withdrawal bleeding usually occurs. This usually starts on day 2-3 after the last tablet and may not have finished before the next pack is started. HOW TO START _ _ • _No preceding hormonal contraceptive use (in the past month) _ _ _ Desogestrel/Ethinylestradiol, tablets, NL/H/2673/002, 03.04.2023 rvg 112201 EU SPC II-025 met NL info-clean Tablet-taking has to start on day 1 of the woman’s natural cycle (i.e. the first day of her menstrual bleeding). Tablet intake is also allowed to start on day 2-5, but during the first cycle concurrent use of a barrier method for the first 7 days of tablet intake is advisable. • _Changing from a combined hormonal contraceptive (combined oral co